Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-aplt
/
Applied Therapeutics Inc
APLT
Add to Watchlist
0.103
USD
0.000
0.00%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
15.70M
Market Cap
Loss
P/E TTM
Applied Therapeutics Inc
0.103
0.000
0.00%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
14.26%
Knoll Capital Management, LLC
3.97%
Propel Bio Management, LLC
3.95%
Shendelman (Shoshana)
3.10%
BlackRock Institutional Trust Company, N.A.
2.13%
Other
72.59%
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
14.26%
Knoll Capital Management, LLC
3.97%
Propel Bio Management, LLC
3.95%
Shendelman (Shoshana)
3.10%
BlackRock Institutional Trust Company, N.A.
2.13%
Other
72.59%
Shareholder Types
Shareholders
Proportion
Investment Advisor
17.42%
Hedge Fund
7.34%
Individual Investor
6.54%
Venture Capital
3.95%
Investment Advisor/Hedge Fund
2.15%
Research Firm
1.97%
Family Office
1.73%
Other
58.89%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
281
56.42M
37.00%
-82.84M
2025Q4
287
97.84M
88.73%
+35.76K
2025Q3
292
106.29M
94.56%
+6.71M
2025Q2
289
99.56M
107.53%
-29.91M
2025Q1
285
124.25M
107.36%
-27.74M
2024Q4
279
133.10M
101.85%
+4.37M
2024Q3
242
127.07M
108.42%
+7.76M
2024Q2
208
119.12M
99.30%
+10.68M
2024Q1
206
108.21M
70.57%
+27.60M
2023Q4
194
71.53M
65.75%
+19.71M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Investment Management, Inc.
21.75M
14.26%
+344.54K
+1.61%
Dec 31, 2025
Knoll Capital Management, LLC
6.05M
3.97%
-1.75M
-22.43%
Dec 31, 2025
Propel Bio Management, LLC
6.02M
3.95%
+6.02M
--
Dec 29, 2025
Shendelman (Shoshana)
4.72M
3.1%
-567.10K
-10.72%
Aug 14, 2024
BlackRock Institutional Trust Company, N.A.
3.25M
2.13%
-529.01K
-13.99%
Dec 31, 2025
Renaissance Technologies LLC
2.71M
1.77%
+2.71M
--
Dec 31, 2025
Funtleyder (Leslie D)
2.05M
1.34%
+150.00K
+7.90%
Jan 01, 2026
Geode Capital Management, L.L.C.
1.49M
0.98%
+214.75K
+16.80%
Dec 31, 2025
Bailey (Evan Prescott)
1.28M
0.84%
+437.50K
+51.98%
Dec 19, 2025
Adage Capital Management, L.P.
1.21M
0.79%
-1.00M
-45.22%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Simplify Propel Opportunities ETF
7.63%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.01%
Humankind US Stock ETF
0%
Hypatia Women CEO ETF
0%
ProShares Hedge Replication ETF
0%
State Street SPDR S&P Biotech ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Value ETF
0%
View more
Simplify Propel Opportunities ETF
Proportion
7.63%
Invesco Nasdaq Biotechnology ETF
Proportion
0.02%
iShares Biotechnology ETF
Proportion
0.01%
Humankind US Stock ETF
Proportion
0%
Hypatia Women CEO ETF
Proportion
0%
ProShares Hedge Replication ETF
Proportion
0%
State Street SPDR S&P Biotech ETF
Proportion
0%
Proshares Ultra Russell 2000
Proportion
0%
ProShares UltraPro Russell2000
Proportion
0%
iShares Russell 2000 Value ETF
Proportion
0%